Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation

Bone Marrow Transplant. 2022 Feb;57(2):271-275. doi: 10.1038/s41409-021-01499-0. Epub 2021 Oct 20.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Cytomegalovirus
  • Cytomegalovirus Infections* / etiology
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • T-Lymphocytes, Cytotoxic